Roving Reporter Asks: How Are CGT Companies Rethinking Pricing and Reimbursement?
July 7, 2026
IBTV speaks with industry leaders at ARM’s Meeting on the Med 2026 to explore how cell and gene therapy companies are approaching pricing, reimbursement, and access as more potentially curative therapies reach patients
1 min read